MITROTTI, PIERFRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 96
AS - Asia 75
NA - Nord America 66
SA - Sud America 18
AF - Africa 10
Totale 265
Nazione #
US - Stati Uniti d'America 63
IT - Italia 52
SG - Singapore 23
CN - Cina 19
RU - Federazione Russa 16
BR - Brasile 14
VN - Vietnam 12
HK - Hong Kong 11
DE - Germania 7
ZA - Sudafrica 6
FR - Francia 4
GB - Regno Unito 4
BD - Bangladesh 3
IN - India 3
ID - Indonesia 2
MA - Marocco 2
MX - Messico 2
NL - Olanda 2
PY - Paraguay 2
SE - Svezia 2
AR - Argentina 1
AT - Austria 1
BE - Belgio 1
BO - Bolivia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
IE - Irlanda 1
JP - Giappone 1
KE - Kenya 1
LT - Lituania 1
PL - Polonia 1
TR - Turchia 1
UA - Ucraina 1
Totale 265
Città #
Singapore 16
Milan 14
San Jose 12
Hong Kong 10
Rome 10
Ashburn 8
Beijing 8
Los Angeles 7
Dallas 6
Johannesburg 5
Boardman 4
Ho Chi Minh City 4
Moscow 4
Turin 4
Florence 3
Biên Hòa 2
Buffalo 2
Dhaka 2
Düsseldorf 2
Hanoi 2
Lauterbourg 2
Munich 2
Naples 2
New York 2
Orem 2
Osio Sotto 2
Rio de Janeiro 2
Santa Clara 2
Shanghai 2
Stockholm 2
Treviso 2
Vigevano 2
Araçagi 1
Asunción 1
Bandung 1
Belo Horizonte 1
Besançon 1
Boston 1
Braço do Norte 1
Brno 1
Cairo 1
Cape Town 1
Casablanca 1
Castelraimondo 1
Changzhou 1
Chengdu 1
Chennai 1
Chicago 1
Cochabamba 1
Criciúma 1
Dublin 1
Estrela dOeste 1
Falkenstein 1
Fortaleza 1
General Rodríguez 1
Haikou 1
Hyderabad 1
Istanbul 1
Juárez 1
Kowloon City 1
Kyiv 1
Liège 1
Magenta 1
Mexico City 1
Nairobi 1
Nam Định 1
Natal 1
Navi Mumbai 1
Ninh Bình 1
Nuremberg 1
Palangkaraya 1
Parma 1
Pavia 1
Petrolina 1
Piscataway 1
Quận Một 1
Registro 1
Santa Cruz do Sul 1
Santa Rita 1
Santo Domingo 1
South Ockendon 1
São Paulo 1
Tokyo 1
Volta Redonda 1
Warsaw 1
Zurich 1
Ấp Tháp Mười 1
Totale 204
Nome #
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 101
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 66
Bilateral Dentate Nuclei Hyperintensities and Response to 4-Aminopyridine in a Patient With Childhood-Onset GAA- FGF14 -Related Ataxia 61
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 42
Totale 270
Categoria #
all - tutte 1.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202432 0 0 0 0 0 4 6 4 0 3 9 6
2024/202593 3 2 2 0 6 10 20 8 20 4 4 14
2025/2026145 10 4 13 16 29 7 24 11 21 10 0 0
Totale 270